Literature DB >> 22570390

Costs associated with data collection and reporting for diabetes quality improvement in primary care practices: a report from SNOCAP-USA.

David R West1, Tiffany A Radcliff, Tiffany Brown, Murray J Cote, Peter C Smith, W Perry Dickinson.   

Abstract

PURPOSE: Information about the costs and experiences of collecting and reporting quality measure data are vital for practices deciding whether to adopt new quality improvement initiatives or monitor existing initiatives.
METHODS: Six primary care practices from Colorado's Improving Performance in Practice program participated. We conducted structured key informant interviews with Improving Performance in Practice coaches and practice managers, clinicians, and staff and directly observed practices.
RESULTS: Practices had 3 to 7 clinicians and 75 to 300 patients with diabetes, half had electronic health records, and half were members of an independent practice association. The estimated per-practice cost of implementation for the data collection and reporting for the diabetes quality improvement program was approximately $15,552 per practice (about $6.23 per diabetic patient per month). The first-year maintenance cost for this effort was approximately $9,553 per practice ($3.83 per diabetic patient per month).
CONCLUSIONS: The cost of implementing and maintaining a diabetes quality improvement effort that incorporates formal data collection, data management, and reporting is significant and quantifiable. Policymakers must become aware of the financial and cultural impact on primary care practices when considering value-based purchasing initiatives.

Entities:  

Mesh:

Year:  2012        PMID: 22570390     DOI: 10.3122/jabfm.2012.03.110049

Source DB:  PubMed          Journal:  J Am Board Fam Med        ISSN: 1557-2625            Impact factor:   2.657


  1 in total

1.  Cost of Transformation among Primary Care Practices Participating in a Medical Home Pilot.

Authors:  Grant R Martsolf; Ryan Kandrack; Robert A Gabbay; Mark W Friedberg
Journal:  J Gen Intern Med       Date:  2015-12-29       Impact factor: 5.128

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.